
Neuland Laboratories Limited
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- ₹3482.15
- Today's High:
- ₹3741.05
- Open Price:
- ₹3741.05
- 52W Low:
- ₹1182.2134
- 52W High:
- ₹4338
- Prev. Close:
- ₹3579.8999
- Volume:
- 1747
Company Statistics
- Market Cap.:
- ₹8.97 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Neuland Laboratories Limited had its IPO on under the ticker symbol 524558.
The company operates in the Other sector and Other industry. Neuland Laboratories Limited has a staff strength of 0 employees.
Stock update
Shares of Neuland Laboratories Limited opened at ₹3741.05 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹3482.15 - ₹3741.05, and closed at ₹3505.1.
This is a -2.09% slip from the previous day's closing price.
A total volume of 1,747 shares were traded at the close of the day’s session.
In the last one week, shares of Neuland Laboratories Limited have slipped by -3.29%.
Neuland Laboratories Limited's Key Ratios
Neuland Laboratories Limited has a market cap of ₹8.97 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Neuland Laboratories Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Neuland Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Neuland Laboratories Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Neuland Laboratories Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Neuland Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Neuland Laboratories Limited’s profitability.
Neuland Laboratories Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Neuland Laboratories Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹15.80 billion
- Total Liabilities
- ₹4.39 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Neuland Laboratories Limited ended 2025 with ₹15.80 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹15.80 billion while shareholder equity stood at ₹9.94 billion.
Neuland Laboratories Limited ended 2025 with ₹0 in deferred long-term liabilities, ₹4.39 billion in other current liabilities, 129005000.00 in common stock, ₹9.81 billion in retained earnings and ₹2.79 billion in goodwill. Its cash balance stood at ₹454.16 million and cash and short-term investments were ₹661.33 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹742.46 million.
Neuland Laboratories Limited’s total current assets stands at ₹7.61 billion while long-term investments were ₹0 and short-term investments were ₹70.29 million. Its net receivables were ₹3.62 billion compared to accounts payable of ₹1.71 billion and inventory worth ₹2.79 billion.
In 2025, Neuland Laboratories Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Neuland Laboratories Limited paid ₹0 in dividends in 2025.
Other key metrics
- Current Trading Price
- ₹3505.1
- 52-Week High
- ₹4338
- 52-Week Low
- ₹1182.2134
- Analyst Target Price
- ₹
Neuland Laboratories Limited stock is currently trading at ₹3505.1 per share. It touched a 52-week high of ₹4338 and a 52-week low of ₹4338. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹3568.27 and 200-day moving average was ₹2393.05 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.